Testing a self-identification program for adults with depression
Tests a self-identification therapy program against acceptance and commitment therapy in adults with depression.
Plain-language title generated from the registry record
Registry title: Self-Identification Program
Key facts
- Where
- Montpellier, FranceSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a current major depressive episode. It tests a talking therapy program on self-identification against another talking therapy.
- Age
- 18 to 70 years
- Sex
- All sexes can join.
- Disease stage
- A current major depressive episode, as part of unipolar or bipolar depressive disorder (DSM criteria).
Main reasons for not taking part
- A psychotic disorder
- Active thoughts of suicide with intention to act (C-SSRS suicidal ideation in the last week 4 or more)
- Pregnant or breastfeeding women
- Adults protected by law, under guardianship or curatorship, or under judicial protection
- Not affiliated to a French social security scheme
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
Source: NCT06183359, who can take part
Where in France
- CHU MontpellierMontpellier, FranceContact: Déborah Ducasse, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University Hospital, Montpellier
- Trial code
- NCT06183359
- Record updated
- 30 September 2025
- Original description
Conduct a pilot, single-center, randomized controlled 2-arm study aimed to evaluate the impact of an in-depth 3rd wave CBT program targeting correct self-identification (3rd level of 3rd wave CBT), compared to a control group receiving an acceptance and commitment therapy (ACT; (1st level of 3rd wave CBT, a well-known psychotherapy). Main judgment criteria : Therapeutic response (reduction ≥ 50% between pre and immediate post-treatment), and rate of relapse at 6 months post-therapy. Secondary objectives: Evaluate psychological processes involved in the reduction of moral pain, diligence, ruminations, suicidal ideas, self-concept and alterations in functioning (mental and social), psychological skills.Read full original descriptionShow less
Correct Self-identification Program in the Treatment of Depression: a Randomized Controlled Trial
Conduct a pilot, single-center, randomized controlled 2-arm study aimed to evaluate the impact of an in-depth 3rd wave CBT program targeting correct self-identification (3rd level of 3rd wave CBT), compared to a control group receiving an acceptance and commitment therapy (ACT; (1st level of 3rd wave CBT, a well-known psychotherapy). Main judgment criteria : Therapeutic response (reduction ≥ 50% between pre and immediate post-treatment), and rate of relapse at 6 months post-therapy. Secondary objectives: Evaluate psychological processes involved in the reduction of moral pain, diligence, ruminations, suicidal ideas, self-concept and alterations in functioning (mental and social), psychological skills.
Inclusion: Patients aged 18 to 70 years, presenting a current major depressive episode (according to DSM 571), as part of unipolar or bipolar depressive disorder.
Exclusion: Exclusion period determined by a previous study; Patients with a psychotic disorder; Patients with active thoughts of suicide with intention to carry out the act (C-SSRS "ideation suicidal" in the last week ≥ 4); Inability to receive informed information about the study; Adult protected by law or patient under guardianship or curatorship; Not be affiliated to a French social security scheme or beneficiary of such a scheme; Not being able to give informed written consent; Pregnant or breastfeeding women; Patients under judicial protection.